Wolverine Trading
IOVA icon

Wolverine Trading’s Iovance Biotherapeutics IOVA Stock Holding History

Wolverine Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$48.5K Buy
+21,739
New +$51.3K ﹤0.01% 5418
2025
Q2 		– Sell
-28,010
Closed -$99.7K – 5160
2025
Q1 		$99.7K Sell
28,010
-13,532
-33% -$69.8K ﹤0.01% 4223
2024
Q4 		$298K Sell
41,542
-10,178
-20% -$94.3K ﹤0.01% 4022
2024
Q3 		$497K Buy
51,720
+17,725
+52% +$168K ﹤0.01% 3057
2024
Q2 		$273K Buy
33,995
+3,544
+12% +$38K ﹤0.01% 3501
2024
Q1 		$451K Sell
30,451
-91,676
-75% -$1.07M ﹤0.01% 2935
2023
Q4 		$993K Buy
122,127
+63,265
+107% +$331K ﹤0.01% 2313
2023
Q3 		$268K Buy
58,862
+2,243
+4% +$14.6K ﹤0.01% 3427
2023
Q2 		$399K Buy
56,619
+23,451
+71% +$168K ﹤0.01% 2819
2023
Q1 		$204K Buy
+33,168
New +$229K ﹤0.01% 3390
2022
Q4 		– Sell
-16,279
Closed -$127K – 4468
2022
Q3 		$155K Buy
+16,279
New +$188K ﹤0.01% 3741
2022
Q2 		– Sell
-15,912
Closed -$209K – 5091
2022
Q1 		$266K Sell
15,912
-576
-3% -$8.91K ﹤0.01% 4057
2021
Q4 		$320K Sell
16,488
-7,771
-32% -$171K ﹤0.01% 4055
2021
Q3 		$577K Sell
24,259
-4,690
-16% -$111K ﹤0.01% 3722
2021
Q2 		$762K Buy
+28,949
New +$752K ﹤0.01% 3132

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wolverine Trading's IOVA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2025: 21,739 shares worth $48.5K. The stake represents ﹤0.01% of the portfolio and ranks #5418 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IOVA as recently as Q1 2025.

Wolverine Trading first reported a position in IOVA in Q2 2021 and has held it in 15 quarters since. The position peaked at $993K in Q4 2023. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Wolverine Trading held 21,739 shares of Iovance Biotherapeutics worth $48.5K as of Q3 2025.
  • Iovance Biotherapeutics was a new Wolverine Trading position in Q3 2025.
  • Iovance Biotherapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5418 holding.
  • Wolverine Trading first reported a position in Iovance Biotherapeutics in Q2 2021 and has held it in 15 quarters since.
  • Wolverine Trading's Iovance Biotherapeutics position peaked at $993K in Q4 2023.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.